4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-109448
Chief Medical Officer sold 6,871 shares at $5.98 ($41,089)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Dan Chief Medical Officer | 2024-09-25 | Sale 10b5-1 | −6,871 | $5.98 | $41,089 | 344,656 | D |
| Open-market sales · 6,871 sh · avg $5.98 · $41,089 | |||||||
Loading xslF345X05/ownership.xml…